Intellectual Property India Publishes Patent Application for 'Hemagglutinin Based Immunogenic Polypeptides, Compositions And Methods Thereof' Filed by Mynvax Private Limited; and Indian Institute Of Science

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202441072850 A) filed by Mynvax Private Limited; and Indian Institute Of Science, Bangalore, Karnataka, on Sept. 26, 2024, for 'hemagglutinin based immunogenic polypeptides, compositions and methods thereof.'

Inventor(s) include Varadarajan, Raghavan; Srivastava, Simran; and Bhasin, Munmun.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to immunogenic polypeptides for eliciting an immune 5 response against influenza. These polypeptides are suitable for use in combination with hemagglutinin (HA)-containing influenz...